First oral hair loss therapy in 30 years shows promising Phase 3 results

Veradermics announced positive Phase 3 clinical trial results for VDPHL01, an oral therapy designed to stimulate hair growth. If approved, it would be the first oral hair loss therapy in 30 years. Previous oral options have been limited to drugs used for decades.